GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sage Therapeutics Inc (FRA:SG7) » Definitions » Pretax Margin %

Sage Therapeutics (FRA:SG7) Pretax Margin % : -788.04% (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sage Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Sage Therapeutics's Pre-Tax Income for the three months ended in Sep. 2024 was €-84.29 Mil. Sage Therapeutics's Revenue for the three months ended in Sep. 2024 was €10.70 Mil. Therefore, Sage Therapeutics's pretax margin for the quarter that ended in Sep. 2024 was -788.04%.

The historical rank and industry rank for Sage Therapeutics's Pretax Margin % or its related term are showing as below:

FRA:SG7' s Pretax Margin % Range Over the Past 10 Years
Min: -9904.46   Med: -3779.1   Max: 54.4
Current: -317.29


FRA:SG7's Pretax Margin % is ranked worse than
59.94% of 1011 companies
in the Biotechnology industry
Industry Median: -148.6 vs FRA:SG7: -317.29

Sage Therapeutics Pretax Margin % Historical Data

The historical data trend for Sage Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sage Therapeutics Pretax Margin % Chart

Sage Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9,904.77 54.40 -7,258.36 -6,931.48 -626.33

Sage Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,423.46 -41.95 -1,372.82 -1,188.45 -788.04

Competitive Comparison of Sage Therapeutics's Pretax Margin %

For the Biotechnology subindustry, Sage Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sage Therapeutics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sage Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Sage Therapeutics's Pretax Margin % falls into.



Sage Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Sage Therapeutics's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-496.545/79.279
=-626.33 %

Sage Therapeutics's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-84.289/10.696
=-788.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sage Therapeutics  (FRA:SG7) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Sage Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Sage Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sage Therapeutics Business Description

Traded in Other Exchanges
Address
215 First Street, Cambridge, MA, USA, 02142
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Sage Therapeutics Headlines

No Headlines